John Rice

Bio

John is Managing Director, Life Sciences at Cincytech, LLC, a venture development company focusing on seed venture capital investment and a co-founder and former Managing Partner of Triathlon Medical Ventures, both in based in Cincinnati. He has 29 years of venture investing and 13 years of research and R&D management experience in biomedical science. He has strong relationships in the scientific community from the 26 years he spent in biomedical research and R&D management at Battelle and Senmed. John was a Managing Director of Senmed Medical Ventures from 1989 until 2003. Previously, John spent 13 years with Battelle Memorial Institute serving in various research, research management, and business development capacities. John is a member of the Boards of, Eccrine Systems and Enable Injections, and Chaiman of Airway Therapeutics, Xact Medical, Genetesis and Myonexus. He has served previously on the boards of Aerpio (ARPO), Akebia (AKBA) (Founder and Chairman), Kereos, Syntherix (CEO), CS-Keys and as an obvserver at Endocyte (ECYT) and Colucid Pharmaceuticals (CLCD). John is also a member of the Board of Directors of Meridian Biosciences (VIVO). John is a member Board of the Global Cardiovascular Innovation Center at the Cleveland Clinic and Board Chairman of the NeuroInnovations Translator at OSU, and Chairman of the Investment Advisory Board of the Harrington Discovery Institute. He serves on the advisory boards of the Innovation Fund at Cincinnati Children's Hospital Medical Center and the University of Cincinnati Accelerator. He is a past member of the board and past chair of BioOhio and BioStart and the Industry Advisory Board of the Case - Coulter Partnership at Case Western Reserve. He has authored numerous scientific publications and holds patents in the fields of virology and immunology. John earned BS, MS and PhD degrees in Microbiology and Virology from The Ohio State University.